Company intelligence / Profile preview

CAS Weizhi

Tongxiang, Zhejiang Province, 中国（China）english.ibp.cas.cn ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Zhejiang Weishi Biotechnology is a commercial-stage manufacturer specializing in the production of vitamins, nutritional additives, and related nutraceuticals. The company utilizes proprietary microencapsulation technology to enhance product quality. It has integrated the full vitamin D3 industry chain and expanded into vitamin D2 and cholesterol technical transformation projects. No clinical trial results are reported as their products are not pharmaceuticals requiring such trials.

Therapeutic areas: ImmunologyOther
Modalities: Small moleculeVitaminNutritional additivePharmaceutical intermediate
Industry: Food & Nutrition

Beyond the preview

Go deeper on CAS Weizhi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAS Weizhi.

Explore the full profile